Skip to main content

Table 1 Antibodies employed in the immunohistochemical study and results

From: Title: pancreatic‐type mixed acinar neuroendocrine carcinoma of the stomach: a case report and review of the literature

  Growth pattern     
Antibody Acinar-glandular pattern Solid pattern Overlying gastric mucosa Clone Source Dilution
BCL-10 +++ ++ 331.3 Santa Cruz Biotechnology 1:50
Trypsin +++ ++   Merck Millipore 1:2000
Chromogranin A + +++ SP12 Thermo Fisher Scientific 1:75
Synaptophysin + ++ SP11 Thermo Fisher Scientific 1:75
CD56 + ++   Nichirei Bioscience prediluted
Amylase + + +  
Insulin   DakoCytomation 1:100
Glucagon   DakoCytomation 1:200
Gastrin   DakoCytomation 1:300
Serotonin   DakoCytomation 1:50
Somatostatin   Roche prediluted
Pancreatic polypeptide   DakoCytomation 1:600
β-catenin + (cell membrane, cytoplasm)   DakoCytomation 1:200
CK7 + OV-TL12/30 DakoCytomation 1:75
CK19 + RCK108 DakoCytomation 1:75
CK20 + KS20.8 DakoCytomation 1:75
CAM5.2 + + +   Becton, Dickinson and Company prediluted
CKAE1/AE3 + + +   DakoCytomation prediluted